Takeda Pharmaceutical Company Limited logo

TAK

Takeda Pharmaceutical Company Limited

$14.5

Earnings Summary

Revenue
$416795Mn
Net Profits
$24773Mn
Net Profit Margins
5.94%

Highlights

Revenue:

Takeda Pharmaceutical Company Limited’s revenue fell -8.95% since last year same period to $416795Mn in the Q3 2016. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -3.97% fall in its revenue since last 3-months.

Net Profits:

Takeda Pharmaceutical Company Limited’s net profit fell -16.87% since last year same period to $24773Mn in the Q3 2016. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -75.11% fall in its net profits since last 3-months.

Net Profit Margins:

Takeda Pharmaceutical Company Limited’s net profit margin fell -8.71% since last year same period to 5.94% in the Q3 2016. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -74.08% fall in its net profit margins since last 3-months.

Earnings per share (EPS) Estimates

Earnings per share (EPS) estimates of the Takeda Pharmaceutical Company Limited post its latest quarter earnings

EPS Estimate Current Quarter
0.25
EPS Estimate Current Year
0.25

Highlights

EPS Estimate Current Quarter:

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.25 - a 41.32% jump from last quarter’s estimates.

EPS Estimate Current Year:

Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.25.

Key Ratios

Key ratios of the Takeda Pharmaceutical Company Limited post its Q4 2022 earnings

Earning Per Share (EPS)
0

Highlights

Earning Per Share (EPS):

Takeda Pharmaceutical Company Limited’s earning per share (EPS) fell -100% since last year same period to 0 in the Q4 2022. This indicates that the Takeda Pharmaceutical Company Limited has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Earnings Calendar

Earnings DateEstimated EPSReported EPSSurprise %
2022-03-31
0.06
-0.03
-144.72%
2022-09-30
0.18
0
-100%
2022-06-30
0.24
0.25
7.03%
2023-02-02
0.25
0
-100%

Company Information

The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.

Organisation
Takeda Pharmaceutical Company Limited
Headquarters
1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668
Employees
47347
Industry
Health Technology
CEO
Christophe Weber

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*